KINTAI Obtains Patent for Invention of Mangiferin

2024-01-18

 

Mangiferin is a natural polyphenol compound extracted from mango leaves of Anacardiaceae or Anemarrhena asphodeloides of Liliaceae. Mangiferin has multiple pharmacological effects, such as antioxidant, anti-tumor, antibacterial, antiviral, hypoglycemic, anti-inflammatory, choleretic and immunomodulatory. However, since mangiferin is almost insoluble in water, has poor solubility and low bioavailability, this has limited its research and development and application as a new drug to a certain extent.

KINTAI's Patent on Mangiferin

In order to solve this problem, KINTAI's researchers have invented a new method for preparing mangoside after extensive research. The patent not only reveals the multiple biological activities of mangoside, but also proposes an innovative preparation method, which greatly improves the solubility and bioavailability of mangoside.

The patent for mangoside and its preparation method is not only a recognition of the hard work of researchers, but also provides strong support for the further development and application of mangoside. It is believed that in the near future, mangoside will play an important role in more fields and make greater contributions to human health.

For more information about KINTAI or mangiferin, please contact us at info@kintaibio.com.